OR WAIT null SECS
Cheryl Barton is director of PharmaVision, info@pharmavision.co.uk.
April 02, 2024
The European pharma industry needs to be prepared for the new clinical data requirements.
March 02, 2024
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 02, 2024
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
January 03, 2024
Novel molecular glues are transforming targeted protein degradation.
January 02, 2024
The EHDS aims to increase access to health data, but how will it impact pharma?
December 02, 2023
What does the 2024 VPAS mean for pharma?